巴拉顿和科米诺:Faricimab对视网膜静脉封闭的第三阶段随机临床试验:研究设计和理由
Lars-Olof Hattenbach1, Francis Abreu2, Pablo Arrisi3
1Augenklinik des Klinikums Ludwigshafen, Ludwigshafen, Germany.
Ophthalmology science
|October 9, 2023
概括
法里西马布是一种双抗血管素-2和VEGF-A抑制剂,在治疗由于视网膜静脉封闭引起的黄斑胀时表现出有效性和耐久性. 在BALATON/COMINO试验中,研究了其安全性和个性化治疗间隔.
科学领域:
- 眼科医生 眼科 眼科
- 视网膜疾病 视网膜疾病
- 药理学 药理学是指药理学的学科.
背景情况:
- 由于视网膜静脉封闭 (RVO) 的次要性斑点 (ME) 显著影响视力.
- 目前的治疗方法往往需要频繁的静脉内注射.
- 双抑制提供了一个潜在的新疗法途径.
研究的目的:
- 调查法里西马布在因RVO引起的ME患者的疗效,安全性和耐久性.
- 为了比较法里西马布与aflibercept在以前没有接受过抗VEGF治疗的患者中.
- 为了评估一个个性化的治疗间隔剂量治疗方案为faricimab.
主要方法:
- 第三阶段,全球性,随机,双面罩,主动对比者控制的研究 (BALATON/COMINO).
- 1282名先前未接受抗VEGF治疗的RVO患者随机分别接受每月6.0毫克法里西马布或2.0毫克阿弗利伯塞普6个月.
- 以后的个性化治疗间隔与法里西马布基于BCVA和CST使用自动化算法.
主要成果:
- 主要终点:法利西马布与阿弗利塞普特在24周的BCVA中从基线平均变化的非劣势.
- 二级终点包括BCVA,CST,视觉功能的变化,以及实现特定字母增长的患者比例.
- 在整个研究期间评估了安全性和耐受性数据.
结论:
- 法里西马布在治疗RVO次要的ME方面表现有前途,为持久的视力增长提供了潜力.
- 该研究提供了使用自动间隔算法的个性化治疗策略的见解.
- 需要进一步评估法里西马布在RVO中的长期安全性和有效性.
相关概念视频
Clinical Trials: Overview
3.0K
Clinical development focuses on how the drug will interact with the human body and encompasses four key phases of clinical trials, each serving a specific purpose in assessing the safety and effectiveness of new drugs. These phases overlap and build upon one another. Phase I involves a small group of healthy volunteers (typically 20-80 individuals) or, in cases where significant toxicity is expected, patients with the targeted disease, such as cancer or AIDS. The volunteers are tested for...
3.0K
Clinical Trials
6.8K
Clinical trials are prospective experimental studies conducted on humans to determine the safety and efficacy of treatments, drugs, diet methods, and medical devices. Using statistics in clinical trials enables researchers to derive reasonable and accurate conclusions from the collected data, allowing them to make wise decisions in uncertain situations. In medical research, statistical methods are crucial for preventing errors and bias.
There are four phases in a clinical trial. A phase one...
There are four phases in a clinical trial. A phase one...
6.8K
Venous Thrombosis II: Clinical Manifestations and Diagnostic Studies
13
The key difference between Superficial Vein Thrombosis (SVT) and Deep Vein Thrombosis (DVT) lies in their location and severity.Clinical ManifestationsSVT typically presents with localized pain, tenderness, and redness along the course of a superficial vein, often accompanied by a palpable, cord-like structure under the skin. This condition is usually less dangerous than DVT but can be uncomfortable and may lead to complications such as cellulitis or, rarely, a clot extension into the deep...
13
Open Angle Glaucoma: Treatment
472
In open-angle glaucoma, the iridocorneal angle remains open, but the trabecular meshwork becomes stiff, slowing down the outflow of aqueous humor. This causes a buildup of aqueous humor in the anterior chamber, leading to a sudden increase in intraocular pressure. The treatment for open-angle glaucoma focuses on reducing the elevated intraocular pressure by either decreasing the secretion of aqueous humor or increasing its outflow.
Drugs such as carbonic anhydrase inhibitors, α2- and...
Drugs such as carbonic anhydrase inhibitors, α2- and...
472
Venous Thrombosis III: Interprofessional Care
10
Venous thrombosis requires effective prevention and treatment strategies to improve patient outcomes and reduce potential complications.Prevention StrategiesHealthcare providers must prioritize preventing venous thromboembolism (VTE) for all adult patients upon admission. Interventions depend on bleeding and thrombosis risk, medical history, current medications, diagnoses, planned procedures, and patient preferences. Patients on bed rest should change positions every two hours and, if not...
10
Angle Closure Glaucoma: Treatment
546
Angle-closure glaucoma, or closed-angle glaucoma, is an eye condition where the iris bulges out and blocks the iridocorneal angle, resulting in a buildup of aqueous humor and increased intraocular pressure. Immediate medical attention is necessary due to the sudden onset of symptoms. The treatment for angle-closure glaucoma includes short-term and long-term approaches. Short-term treatment involves using eye drops like pilocarpine to lower intraocular pressure by increasing aqueous humor...
546


